Erik B. Faber

Also affiliated with University of Minnesota Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Defining and Characterizing Frequent Attenders: Systematic Literature Review and Recommendations”.

Defining and Characterizing Frequent Attenders: Systematic Literature Review and Recommendations

Journal of patient-centered research and reviews(2020)10.17294/2330-0698.1747

N/A

0DataRank · unranked

51 citations

Erik B. Faber, Brian Sick, Dip Shukla

Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†

Biology of Reproduction(2020)10.1093/biolre/ioaa107

N/A

0DataRank · unranked

27 citations

Nan Wang, Gunda I. Georg, Erik B. Faber

Development of allosteric, selective cyclin-dependent kinase 2 (CDK2) inhibitors that are negatively cooperative with cyclin binding and show potential as contraceptive agents

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.30.497818

N/A

0DataRank · unranked

4 citations

Jian Tang, Emily Roberts, Sornakala Ganeshkumar, Luxin Sun, Nan Wang +12 more

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

Nature Communications(2023)10.1038/s41467-023-38732-x

N/A

0DataRank · unranked

48 citations

Luxin Sun, Jian Tang, Emily Roberts, Sornakala Ganeshkumar, Nan Wang +13 more

Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01731

N/A

0DataRank · unranked

32 citations

Nan Wang, Kristen John, Luxin Sun, H.L.S. Wong, David J. Burban +12 more

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status

ESMO Gastrointestinal Oncology(2024)10.1016/j.esmogo.2024.100042

N/A

0DataRank · unranked

0 citations

Yasmine Baca, Joanne Xiu, Phillip Walker, Gulam A. Manji, Sepideh Gholami +13 more